RX692 RX692 (Clindamycin 150 mg)
Pill imprint RX692 RX692 has been identified as Clindamycin hydrochloride 150 mg.
Clindamycin is used in the treatment of bacterial vaginitis; bacterial infection; skin infection; sinusitis; babesiosis (and more), and belongs to the drug class lincomycin derivatives. There is no proven risk in humans during pregnancy. Clindamycin 150 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for RX692 RX692
- 150 mg
- Blue / Green
- 19.00 mm
- Prescription only
- Drug Class:
- Lincomycin derivatives
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Ranbaxy Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose monohydrate
FD&C Blue No. 1
D&C Yellow No. 10
ferric oxide black
|NDC Code||Manufacturer / Repackager|
|68084-0243||Amerisource Health Services|
|66336-0018||Dispensing Solutions Inc. (repackager)|
|43063-0056||PDRX Pharmaceuticals Inc (repackager)|
|66267-0060||Nucare Pharmaceuticals Inc (repackager)|
|49999-0011||Lake Erie Medical and Surgical Supply (repackager)|
|57866-0155||Direct Dispensing Inc (repackager)|
|10544-0332||Blenheim Pharmacal Inc (repackager)|
|33358-0088||CorePharma, LLC (repackager)|
|23490-5332||Palmetto State Pharmaceuticals Inc (repackager)|
|55289-0441||PDRX Pharmaceuticals Inc (repackager)|
|21695-0033||Rebel Distributors Corp (repackager)|
|16590-0057||Stat RX USA LLC (repackager)|
Note: Inactive ingredients may vary.
More about clindamycin
- Clindamycin solution
- Clindamycin suspension
- Clindamycin oral/injection
- Clindamycin Oral, Injection, Intravenous (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.